Target intelligence / Profile preview

Immune System Desensitization via Gradual Allergen Exposure

Molecular classification
Immunological process, IgE antibodies, Regulatory T cells
01

Overview

Immune system desensitization via gradual allergen exposure, also known as allergen immunotherapy or exposure therapy, is a medical approach designed to reduce or eliminate allergic reactions by gradually introducing increasing amounts of an allergen to which a person is sensitive. This process aims to retrain the immune system to become less reactive or non-responsive (tolerant) to the specific allergen over time. It involves controlled antigen presentation over time, leading to changes in antibody profiles and regulatory T cell activity.

Other names
Allergen immunotherapyAllergy shotsOral Immunotherapy (OIT)Sublingual ImmunotherapyExposure therapy
02

Mechanism of action

Gradual introduction of increasing allergen doses to shift immune response from IgE-mediated allergy to tolerance through changes in antibody profiles and regulatory T cell activity.

03

Biological functions

Immune response modulationTolerance inductionAntigen presentationAntibody profile alteration
04

Disease associations

Food allergyEnvironmental allergyInsect venom allergyAllergic rhinitisAsthma
05

Safety considerations

Allergic reactions during escalation phasesAnaphylaxisNeed for trained supervision during initial dosing
06

Interacting drugs

Allergens (administered in controlled doses)
07

Biomarkers

Allergen-specific IgE levelsRegulatory T cell activityReaction threshold to allergen exposure

Beyond the preview

Go deeper on Immune System Desensitization via Gradual Allergen Exposure.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune System Desensitization via Gradual Allergen Exposure.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call